Enacts provisions relating to insurance coverage of health care services
Note
As the bill progresses, it will be important to monitor discussions and potential amendments that address concerns from various stakeholders, ensuring that the goal of improving healthcare access without compromising quality or financial stability is met.
Impact
One of the notable impacts of SB846 is the change to prior authorization requirements. Beginning January 1, 2027, healthcare providers will not need to secure prior authorization for certain services unless their approval rates drop below 90%. This change aims to streamline access to necessary health services and reduce administrative burdens faced by providers. Additionally, the bill requires equal reimbursement for 340B drugs, aiming to protect entities involved in this federal drug pricing program from discriminatory practices by health carriers and pharmacy benefits managers.
Summary
Senate Bill 846 aims to amend Chapter 376 of the Revised Statutes of Missouri, introducing provisions related to insurance coverage for healthcare services. The bill specifically addresses practices regarding clinician-administered drugs, aiming to prevent health carriers and pharmacy benefits managers from imposing penalties or limitations on providers offering these medically necessary treatments. Key terms including 'health carrier', 'participating provider', and 'pharmacy benefits manager' are defined to ensure clarity regarding responsibilities and rights within healthcare service delivery.
Contention
Despite the bill's intent to enhance insurance coverage and protect healthcare providers, points of contention may arise concerning how health carriers will adapt to these regulations. Critics may argue that the legislation could lead to increased healthcare costs or challenge the financial models of insurance companies. Moreover, providers must be prepared for audits and compliance checks related to the new rules, which some may perceive as burdensome.